Mounjaro is the brand-name formulation of tirzepatide, designed with specific dosing, delivery mechanisms, and clinical testing to ensure efficacy and safety
[5] [6] It's important to note that while Ozempic may result in weight loss, it is not licensed for weight management in the UK a higher-dose formulation of semaglutide called Wegovy is specifically licensed for obesity treatment in eligible adults
By carefully monitoring your progress and listening to your feedback, your provider can make any necessary adjustments to your dosage or plan
In clinical trial protocols, the drug is initiated at a low dose and titrated gradually upwards to minimise gastrointestinal side effects
Instead, it may possibly produce some fat-burning action via energy expenditure and fat oxidation
For instance, the presence of residual food or delayed transit time might necessitate a repeat endoscopy or additional imaging studies